Kawabe T et al. |
Role of PAF and cytokines in the modulation of Fc epsilon RII/CD23 expression on human eosinophils. |
1991 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:1825444
|
Weber PC and Sellmayer A |
Modification of the eicosanoid system and cell signalling by precursor fatty acids. |
1991 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:1825543
|
Balazy M et al. |
A novel method for the analysis of PAF and alkyl-ether phospholipids by mass spectrometry. |
1991 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:1825562
|
Magni F et al. |
Determination of platelet-activating factor in biological samples by high resolution mass spectrometry. |
1991 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:1825563
|
Coceani F et al. |
Leukotrienes in cerebrospinal fluid of the conscious cat: effect of platelet-activating factor and pyrogens. |
1991 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:1825586
|
Bussolino F et al. |
Chick retina generates platelet-activating factor. |
1987 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2890284
|
Braquet P et al. |
Platelet-activating factor: a potential mediator of shock. |
1987 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2960197
|
Myers A et al. |
Pharmacological manipulation of platelet-activating factor toxicity in rodents. |
1987 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2960198
|
Benveniste J |
Paf-acether (platelet-activating factor). |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:3159192
|
Vargaftig BB et al. |
Synergized activation of human platelets by epinephrine and platelet-activating factor-acether is adenosine diphosphate and thromboxane A2-independent. |
1983 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:6221558
|
Koltai M et al. |
Platelet-activating factor antagonists: scientific background and possible clinical applications. |
1994 |
Adv. Pharmacol. |
pmid:8080821
|
Summers JB and Albert DH |
Platelet activating factor antagonists. |
1995 |
Adv. Pharmacol. |
pmid:7748804
|
Pirotzky E et al. |
Involvement of platelet-activating factor in renal processes. |
1989 |
Adv. Lipid Res. |
pmid:2698054
|
Holleran WM |
Lipid modulators of epidermal proliferation and differentiation. |
1991 |
Adv. Lipid Res. |
pmid:1763711
|
Vadas P and Pruzanski W |
Phospholipase A2 activation is the pivotal step in the effector pathway of inflammation. |
1990 |
Adv. Exp. Med. Biol. |
pmid:2239447
|
Kornecki E et al. |
Interactions of the alkyl-ether-phospholipid, platelet activating factor (PAF) with platelets, neural cells, and the psychotropic drugs triazolobenzodiazepines. |
1987 |
Adv. Exp. Med. Biol. |
pmid:2893525
|
Hallam TJ et al. |
Control and interrelation of aggregation and secretion; the roles of Ca2+, diacylglycerol and thromboxane with particular reference to ADP stimulation. |
1985 |
Adv. Exp. Med. Biol. |
pmid:3010663
|
Snyder F et al. |
Biosynthesis of platelet-activating factor and enzyme inhibitors. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131118
|
Satoh K et al. |
Production of platelet-activating factor by brain microvascular endothelial cells. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131120
|
Yang HC et al. |
Characterization of plasmalogen-selective phospholipase A2 from bovine brain. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9131165
|